Not applicableStudy completedNCT04256408What this trial is testingMind The Gap - Crossing Borders StudyWho this might be right forEmphysemaCOPDHyperinflation Lung University Medical Center Groningen 3
Not applicableStudy completedNCT00528944What this trial is testingSingle-Breath Measurement Underestimates Ventilatory Volume According to Emphysema SeverityWho this might be right forEmphysema Columbia University 73
Early research (Phase 1)Study completedNCT01334307What this trial is testingRandomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)Who this might be right forEmphysema Boston Scientific Corporation 47
Large-scale testing (Phase 3)Looking for participantsNCT06165341What this trial is testingStudy to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)Who this might be right forAlpha1-Antitrypsin Deficiency Takeda 50
Not applicableStudy completedNCT00005292What this trial is testingAlpha1-antitrypsin Deficiency RegistryWho this might be right forLung DiseasesEmphysemaAlpha-1 Antitrypsin Deficiency+1 more National Heart, Lung, and Blood Institute (NHLBI)
Very early researchEnded earlyNCT02748798What this trial is testingDeveloping Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung DisordersWho this might be right forLung TransplantLung ResectionLung Cancer+16 more Thunder Bay Regional Health Research Institute 10
Not applicableUnknownNCT02262884What this trial is testingSurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)Who this might be right forSubcutaneous Emphysema SurgiQuest, Inc. 189
Large-scale testing (Phase 3)Ended earlyNCT02722304What this trial is testingStage 1 Study of ARALAST NP and GLASSIA in A1PI DeficiencyWho this might be right forChronic Obstructive Pulmonary DiseaseAlpha1-antitrypsin Deficiency Baxalta now part of Shire 7
Post-approval studies (Phase 4)Study completedNCT00680056What this trial is testingAdd-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease PatientsWho this might be right forPulmonary Disease, Chronic ObstructiveChronic BronchitisPulmonary Emphysema Federal University of São Paulo 33
Not applicableUnknownNCT02879331What this trial is testingClinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With CoilsWho this might be right forPulmonary Emphysema Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 35
Large-scale testing (Phase 3)WithdrawnNCT01908933What this trial is testingStudy of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous EmphysemaWho this might be right forEmphysemaChronic Obstructive Pulmonary Disease (COPD) Aeris Therapeutics
Testing effectiveness (Phase 2)Ended earlyNCT04167345What this trial is testingEvaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ GenotypeWho this might be right forAlpha 1-Antitrypsin Deficiency Vertex Pharmaceuticals Incorporated 48
Post-approval studies (Phase 4)Study completedNCT00202189What this trial is testingEffects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)Who this might be right forChronic Obstructive Pulmonary Disease Queen's University 4
Early research (Phase 1)UnknownNCT01758055What this trial is testingSafety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema PatientsWho this might be right forEmphysema Arda Kiani 12
Not applicableEnded earlyNCT01608490What this trial is testingLung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) StudyWho this might be right forEmphysema Boston Scientific Corporation 315
Testing effectiveness (Phase 2)Study completedNCT01372410What this trial is testingA Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)Who this might be right forPulmonary Disease, Chronic Obstructive GlaxoSmithKline 163
Early research (Phase 1)Study completedNCT00085852What this trial is testingUS 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial FormulationWho this might be right forPulmonary Emphysema Aeris Therapeutics 6
Testing effectiveness (Phase 2)Study completedNCT01669421What this trial is testingEffect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.Who this might be right forAlpha 1 Antitrypsin Deficiency Michael Campos, MD 10
Not applicableStudy completedNCT01974830What this trial is testingAL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient RegistryWho this might be right forAlpha-1 Anti-trypsin Deficiency Coram Clinical Trials 120
Not applicableEnded earlyNCT01357460What this trial is testingEndoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin DeficiencyWho this might be right forHereditary Emphysema (Alpha 1-antitrypsin Deficiency) Heidelberg University 18